GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
+22.9%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$405M
AUM Growth
+$405M
(-22%)
Cap. Flow
-$212M
Cap. Flow
% of AUM
-52.4%
Top 10 Holdings %
Top 10 Hldgs %
65.03%
Holding
44
New
7
Increased
5
Reduced
15
Closed
8
Top Buys
| 1 |
Kura Oncology
KURA
|
$26.2M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$14.2M |
| 3 |
Sarepta Therapeutics
SRPT
|
$11.3M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$9.47M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$8.58M |
Top Sells
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$49.8M |
| 2 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$41.5M |
| 3 |
Vanda Pharmaceuticals
VNDA
|
$31.1M |
| 4 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$27.6M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$22.1M |
Sector Composition
| 1 | Healthcare | 87.22% |
| 2 | Technology | 0.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZGNX
1
DELISTED
Zogenix, Inc.
ZGNX
| $35.8M | 6.96% | 1,021,331 -1,419,628 | -58% | -$49.8M |
|
|
ARNA
2
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $34.6M | 6.74% | 1,357,800 -1,082,130 | -44% | -$27.6M |
|
|
CNCE
3
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $29.6M | 5.76% | 2,006,211 +6,211 | +0.3% | +$91.6K |
|
4
Neurocrine Biosciences
NBIX
$13.8B
| $29.1M | 5.66% | 475,000 -125,000 | -21% | -$7.66M |
|
|
FOMX
5
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $26.5M | 5.16% | 4,781,708 | – | – |
|
|
6
Kura Oncology
KURA
$686M
| $26.2M | 5.09% | +1,750,887 | New | +$26.2M |
|
7
Rigel Pharmaceuticals
RIGL
$697M
| $23.1M | 4.5% | 9,105,691 | – | – |
|
8
PTC Therapeutics
PTCT
$3.92B
| $22M | 4.28% | 1,100,000 -800,000 | -42% | -$16M |
|
|
DBVT
9
DBV Technologies
DBVT
$264M
| $19.1M | 3.72% | 450,888 -49,112 | -10% | -$2.08M |
|
|
GBT
10
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $17.4M | 3.39% | 560,498 +305,098 | +119% | +$9.47M |
|
11
Cartesian Therapeutics
RNAC
$261M
| $16.5M | 3.2% | 901,847 -35,653 | -4% | -$651K |
|
|
12
Iovance Biotherapeutics
IOVA
$807M
| $15.5M | 3.02% | 2,000,000 +1,830,986 | +1,083% | +$14.2M |
|
|
RXDX
13
DELISTED
Ignyta, Inc.
RXDX
| $15.3M | 2.98% | 1,241,752 -507,571 | -29% | -$6.27M |
|
|
AIMT
14
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $12.4M | 2.41% | 500,000 +64,598 | +15% | +$1.6M |
|
|
15
Sarepta Therapeutics
SRPT
$1.78B
| $11.3M | 2.21% | +250,000 | New | +$11.3M |
|
|
SGYP
16
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $9.49M | 1.85% | 3,273,509 -3,950,000 | -55% | -$11.5M |
|
|
17
Vanda Pharmaceuticals
VNDA
$279M
| $8.91M | 1.73% | 497,531 -1,734,707 | -78% | -$31.1M |
|
|
18
BioCryst Pharmaceuticals
BCRX
$1.74B
| $8.58M | 1.67% | +1,637,332 | New | +$8.58M |
|
|
SAGE
19
DELISTED
Sage Therapeutics
SAGE
| $6.82M | 1.33% | 109,500 -134,300 | -55% | -$8.37M |
|
|
XLRN
20
DELISTED
Acceleron Pharma Inc.
XLRN
| $6.34M | 1.23% | 170,000 -323,500 | -66% | -$12.1M |
|
21
Apyx Medical
APYX
$75.3M
| $6.18M | 1.2% | 1,829,441 -1,094,574 | -37% | -$3.7M |
|
|
ADMS
22
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $5.43M | 1.06% | 256,340 -1,960,011 | -88% | -$41.5M |
|
|
AMRN
23
Amarin Corp
AMRN
$311M
| $3.7M | 0.72% | 1,056,825 -713,175 | -40% | -$2.5M |
|
24
NovoCure
NVCR
$1.38B
| $3.53M | 0.69% | +177,666 | New | +$3.53M |
|
|
MYOV
25
DELISTED
Myovant Sciences Ltd.
MYOV
| $3.53M | 0.69% | 228,008 -19,891 | -8% | -$308K |
|